Amundi boosted its stake in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 169.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,210 shares of the insurance provider's stock after acquiring an additional 5,789 shares during the period. Amundi's holdings in AMERISAFE were worth $456,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. State Street Corp lifted its stake in shares of AMERISAFE by 8.5% in the 3rd quarter. State Street Corp now owns 811,561 shares of the insurance provider's stock valued at $39,223,000 after purchasing an additional 63,638 shares during the period. Barclays PLC increased its holdings in AMERISAFE by 365.6% in the third quarter. Barclays PLC now owns 33,219 shares of the insurance provider's stock worth $1,605,000 after purchasing an additional 26,084 shares in the last quarter. Jane Street Group LLC lifted its stake in AMERISAFE by 70.6% in the third quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider's stock valued at $1,996,000 after buying an additional 17,084 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of AMERISAFE by 6.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,882 shares of the insurance provider's stock worth $284,000 after buying an additional 381 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of AMERISAFE by 1,328.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 5,914 shares of the insurance provider's stock worth $305,000 after buying an additional 5,500 shares in the last quarter. Institutional investors and hedge funds own 97.41% of the company's stock.
AMERISAFE Price Performance
Shares of NASDAQ:AMSF traded up $0.30 during mid-day trading on Monday, hitting $52.02. The company had a trading volume of 64,699 shares, compared to its average volume of 106,349. The company has a market capitalization of $990.98 million, a PE ratio of 16.26 and a beta of 0.33. AMERISAFE, Inc. has a one year low of $41.97 and a one year high of $60.24. The firm has a fifty day moving average price of $50.56 and a 200 day moving average price of $51.94.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The insurance provider reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.07. The firm had revenue of $73.51 million during the quarter, compared to the consensus estimate of $77.37 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. Research analysts expect that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Friday, March 7th were paid a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date was Friday, March 7th. AMERISAFE's dividend payout ratio (DPR) is currently 53.98%.
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Read More

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.